Andrew Lee

Andrew Lee is an experienced medical science liaison with a strong background in oncology and immunology, currently serving as a Senior Medical Science Liaison at Genentech since August 2016, where contributions have spanned lung, genitourinary, dermatology, and immunology oncology. Prior experience includes roles at AstraZeneca and GSK, focusing on rheumatology and Systemic Lupus Erythematosus, respectively. Andrew began the career as a research scientist at UT Southwestern Medical Center and held positions at The Scripps Research Institute and the University of North Carolina at Chapel Hill, where significant research in innate immunity and anti-viral mechanisms was conducted. Academic qualifications include a Ph.D. and a B.A. in Biochemistry & Cell Biology, both from Rice University.